Altogether, PDE4 regulation seems to be implicated in obesity at the level of PDE4B and PDE4D, and an allosteric inhibitor of PDE4D would be effective in the loss of fat mass without changing cognitive function. The gene discussed is PDE4D; the disease is obesity due to melanocortin 4 receptor deficiency.